Non-muscle Invasive Bladder Cancer (NMIBC) Clinical Trials
2 recruiting trials for Non-muscle Invasive Bladder Cancer (NMIBC). Eligibility criteria explained in plain English.
2
Total Trials
2
Recruiting Now
0
Phase 3 Trials
2
Sponsors
Recruiting Trials
RECRUITINGNCT07187063
Using Urine Tumor DNA to De-Intensify Surveillance in Non-Muscle Invasive Bladder Cancer
The goal of this clinical trial is to use urine tumor DNA (utDNA) as an indicator for non-muscle invasive bladder cancer to identify patients suitable for less frequent cystoscopy...
Sponsor: Lahey ClinicEnrolling: 561 location
RECRUITINGPhase 1 / Phase 2NCT07122414
A Study of Intravesical FL115 Alone or in Combination With BCG in Non-Muscle Invasive Bladder Cancer
The study is to evaluate the safety and tolerability of intravesical FL115 alone or in combination with BCG in the patients with NMIBC, and to determine the RP2D of FL115 in...
Sponsor: Suzhou Forlong Biotechnology Co., LtdEnrolling: 8012 locations